Form 4: AMKOR Director Plans Future Stock Option Exercise and Sale
Insider Transaction Report
AMKOR Technology Director MaryFrances McCourt reported a pre-planned exercise of stock options and subsequent sale of 20,000 shares under a Rule 10b5-1 plan.
Summary
- MaryFrances McCourt, a Director of AMKOR Technology, Inc., reported a planned transaction under a Rule 10b5-1 plan.
- On December 12, 2025, she is scheduled to acquire 20,000 shares of Common Stock by exercising a Director Stock Option at a price of $19.39 per share.
- Concurrently, she is scheduled to sell 20,000 shares of Common Stock at a weighted average price of $46.02 per share, with sales expected to range from $45.98 to $46.09 per share.
- Following these planned transactions, her direct beneficial ownership of Common Stock is expected to decrease from 75,918 shares to 55,918 shares.
- The stock option was granted on May 18, 2021, and vested in full on May 17, 2022.
Sentiment
Score: 5
Explanation: The filing reports a pre-planned insider transaction under a Rule 10b5-1 plan, scheduled for a future date. This type of transaction is generally considered neutral as it reflects a pre-determined financial plan rather than a reaction to recent company performance or market conditions.
Positives
- The director is realizing a significant gain by exercising options at $19.39 and selling at a weighted average of $46.02, indicating the stock has performed well since the option grant.
- The transaction is pre-planned under a Rule 10b5-1 plan, which suggests a systematic approach to managing personal holdings rather than a reactive sale based on immediate company news.
Negatives
- A director's planned sale of a significant number of shares, even under a 10b5-1 plan, reduces their direct equity exposure to the company.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May interpret the director's planned sale as a signal, either positive (director realizing value) or neutral (pre-planned financial management).
- Employees: No direct impact.
- Customers/Suppliers/Creditors: No direct impact.
Key Dates
| Date | Description |
|---|---|
| 05/18/2021 | Director Stock Option granted. |
| 05/17/2022 | Director Stock Option vested in full. |
| 12/12/2025 | Date of planned stock option exercise and subsequent sale of common stock. |
| 12/16/2025 | Date Form 4 was signed by Attorney-in-Fact. |
Recommendation
holdThe filing details a pre-planned insider transaction under a Rule 10b5-1 plan, scheduled for a future date. Such transactions are typically for personal financial planning and do not inherently signal a change in the company's fundamental outlook or performance. Therefore, this filing alone does not warrant a change from a 'hold' recommendation.
Keywords
AMKOR Technology, AMKR, Form 4, Insider Trading, Stock Option Exercise, Director Stock Sale, MaryFrances McCourt, Rule 10b5-1 Plan, Semiconductor Packaging
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.